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Abstract 
Background: Previous work suggests that apoptosis is dysfunctional in cystic fibrosis (CF) 
airways with conflicting results. We evaluated the relationship between dysfunctional cystic 
fibrosis transmembrane conductance regulator (CFTR) and apoptosis in CF airway epithelial 
cells.  
Methods: Apoptosis and associated caspase activity were analysed in non-CF and CF tracheal 
and bronchial epithelial cell lines.   
Results: Basal levels of apoptosis and activity of caspase-3 and caspase-8 were significantly 
increased in CF epithelial cells compared to controls, suggesting involvement of extrinsic 
apoptosis signalling, which is mediated by the activation of death receptors, such as Fas 
(CD95). Increased levels of Fas were observed in CF epithelial cells and bronchial brushings 
from CF patients compared to non-CF controls. Neutralisation of Fas significantly inhibited 
caspase-3 activity in CF epithelial cells compared to untreated cells. In addition, activation of 
Fas significantly increased caspase-3 activity and apoptosis in CF epithelial cells compared to 
control cells.   
Conclusions: Overall, these results suggest that CF airway epithelial cells are more sensitive to 
apoptosis via increased levels of Fas and subsequent activation of the Fas death receptor 
pathway, which may be associated with dysfunctional CFTR.  
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Introduction 
Cystic fibrosis (CF) is an autosomal recessive genetic disease caused by mutations in the 
cystic fibrosis transmembrane conductance regulator (CFTR) gene. It affects all exocrine 
organs including the airways, pancreas, intestine and sweat glands, however, pulmonary 
disease causes most of the morbidity and mortality associated with CF [1]. CFTR – a 1480 
amino acid protein that functions as a chloride channel – is highly expressed in the airway 
epithelium where it regulates chloride ion movement [2]. A single deletion of a 
phenylalanine residue at position 508 in CFTR (ΔF508-CFTR) results in a misfolded protein 
that is associated with approximately 90% of CF cases [3]. CF lung disease is associated with 
the failure of pulmonary host defence leading to a vicious cycle of continual infection, 
inflammation and remodelling of lung tissue. The airway epithelium plays a key role in 
pulmonary host defence, and apoptosis is a physiological process essential for homeostasis 
of epithelial function. 
Apoptosis, or programmed cell death, is a form of regulated cell death in which 
activation of specific proteases called caspases leads to DNA cleavage and cell death. 
Previous work suggests that apoptosis is dysfunctional in the CF airways with conflicting 
results. While some reports describe defective apoptosis of epithelial cells expressing 
mutant forms of CFTR [4–6], a number of others report excessive apoptosis in CF cells [7–
13]. In addition, it is unclear how CFTR misfolding and dysfunction contributes to apoptosis 
or the susceptibility of cells to pro-apoptotic stimuli. Nonetheless, accumulation of 
apoptotic cells as evident in the CF lung may precipitate chronic inflammation and 
progressive airway damage [14,15].  
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Previous studies have focused on the effect of external stimuli on apoptosis in CF epithelium 
[8,16]. However, we now show that in basal (unstimulated) CF epithelial cells, indices of 
apoptosis are increased (caspase-3, caspase-8). Further evaluation of upstream apoptotic 
factors demonstrated increased expression of Fas which contributed to the increased 
activation of caspase-3 and -8 demonstrated in these cells. Treatment of CF cells with Fas 
activating antibody, CH-11, resulted in a significant increase in caspase-3 and -8 activation as 
well as significant increase in apoptosis in these cells compared to non-CF cells. Increased 
Fas expression was related to CFTR function as treatment of primary non-CF bronchial 
epithelial cells with a CFTR inhibitor resulted in increased Fas expression in these cells. 
These findings indicate that CF epithelium is in a primed condition for apoptosis which 
results in significant programmed cell death upon activation. These finding may impact on 
effective innate host defence function offered by the epithelial barrier in the CF lung. 
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Methods and materials 
Cell culture 
The human bronchial epithelial cell line (16HBE14o-, HBE), CF bronchial epithelial cell line 
(CFBE41o-, CFBE) homozygous for the ΔF508 mutation, the human tracheal epithelial cell 
line (9HTEo-, HTE) and the CF tracheal epithelial cell line (CFTE29o-, CFTE) homozygous for 
the ΔF508 mutation were obtained as a gift from Prof Dieter Gruenert (California Pacific 
Medical Center Research Institute, San Francisco, CA, USA).  Cell lines were maintained in 
Minimum Essential Medium supplemented with 10% heat-inactivated foetal calf serum, 
2mM L-glutamine and 1% penicillin/streptomycin (PAA Laboratories, Somerset, UK) at 37°C 
under 5% CO2. Normal human bronchial/tracheal epithelial cells (NHBE) were obtained from 
Lonza (Basel, Switzerland) and were cultured according to provided guidelines.   
 
For experiments, non-CF (HBE, HTE) and CF epithelial cell lines (CFBE, CFTE) were adhered 
overnight. Cell-free supernatants were collected following a further 24 hr in fresh media. 
Whole cell lysates for protease activity assays and Western blotting were prepared as 
described below. Total RNA was isolated from cells using TRI Reagent® (Sigma-Aldrich) as 
per manufacturer’s instructions.  
 
Cell treatments 
For caspase-8 inhibitor experiments, CF epithelial cells (CFTE, CFBE) were left untreated or 
treated with Ac-IETD-CHO (10 μM, Enzo Life Sciences, Inc., Exeter, UK) for 24 hr. For CFTR 
inhibitor experiments, non-CF epithelial cells (HTE, HBE, NHBE) were treated ± CFTR 
inhibitor (CFTRinh-172, 10 - 20 μM) for 24 hr. For Fas activation experiments, non-CF and CF 
epithelial cells were treated ± a human Fas activating antibody (clone CH-11, 0.5 μg/ml, 
5 
 
Millipore, Darmstadt, Germany) for 24 hr. For Fas neutralisation experiments, cells were 
treated with 100 ng/ml anti-Fas neutralising antibody (clone ZB4, Millipore) or 
corresponding isotype control mouse (IgG1, R&D Systems Europe Ltd., Abingdon, UK) for 6 
hr. 
 
Bronchial brushing analysis and study approval 
Following informed consent under a protocol approved by Beaumont Hospital Institutional 
Review Board, bronchial brushings were sampled from in individuals with CF (n = 3) and 
non-CF controls (n=3). Total RNA was isolated and reverse transcribed as previously 
described [17]. 
 
Apoptosis detection 
Non-CF and CF epithelial cells were treated ± human Fas activating antibody (clone CH-11, 
0.5 μg/ml, Merck Millipore, Darmstadt, Germany) for 24 hr. Cellular apoptosis (DNA 
fragmentation) was quantified using the TiterTACS™ Colorimetric Apoptosis Detection Kit 
(Trevigen, Gaithersburg, MD). Samples were fixed and labelled as per manufacturer’s 
instructions. The Abs630 nm of the wells was measured in a 96-well microplate reader 
(Synergy HT using Gen5™ software, BioTek UK).  
 
Preparation of whole cell lysates - caspase activity assays and Western blotting 
Cells were lysed on ice in lysis buffer (50 mM Tris-HCL pH7.5, 150 mM NaCl, 5 mM EDTA, 
0.2% Igepal) for caspase activity assays or in RIPA buffer (50 mm Tris-HCl, pH 7.5, 150 mm 
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mm EDTA, 1% Triton X-100) 
supplemented with protease and phosphatase inhibitor cocktails (Roche Applied Science, 
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UK) for Western blotting [18].  Cell lysates were centrifuged at 13,000 x g for 10 min to 
remove insoluble debris and stored at -80°C until required. Total protein concentrations 
were determined using the BCA method (Pierce BCA Assay, Fisher Scientific, Leicestershire, 
UK).  Cellular caspase activity was determined using a panel of fluorogenic substrates: Ac-
Asp-Glu-Val-Asp-7-Amino-4-methylcoumarin (Ac-DEVD-AMC) for caspase-3 and Ac-Ile-Glu-
Thr-Asp-AMC (Ac-IETD-AMC) for caspase-8 (Enzo Life Sciences, Inc., Exeter, UK). Samples 
were incubated with substrate (50 μM) and fluorescence (substrate turnover) was 
determined by excitation at 360 nm and emission at 460 nm in a 96-well microplate reader 
(Synergy HT using Gen5™ software, BioTek UK). The rate of substrate hydrolysis was 
monitored at 37°C every 60 seconds for 1 hr and results results were expressed as relative 
fluorescence unit (RFU)/min and normalised to protein concentration. For Western blotting, 
denatured samples were separated by electrophoresis on SDS-polyacrylamide gels, 
transferred to nitrocellulose membrane and probed using rabbit anti-caspase-3 (Cell 
Signalling), caspase-8 (Cell Signalling), rabbit anti-Bid (Cell Signalling), mouse anti-Fas or 
rabbit anti-GAPDH (Santa Cruz Biotechnology Inc.). Binding was detected using the 
appropriate horseradish peroxidase-conjugated secondary antibodies (Fisher Scientific UK), 
visualized by chemiluminescence (GE Healthcare UK, Buckinghamshire) and analysed using 
the Syngene G:Box and GeneSnap software (SynGene UK, Cambridge). 
 
RT-PCR 
Cell line total RNA was isolated and reverse transcribed as previously described [18]. This 
was carried out using primers (Invitrogen) for caspase-3 (sense 5′-
TTCAGAGGGGATCGTTGTAGAAGTC-3’; antisense 5’-CAAGCTTGTCGGCATACTGTTTCAG-3’), 
Fas (sense 5’-TAGAAGCTTCGGAGGATTGCTCAACAAC-3’; antisense 5’-
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TAGGAATTCTTGGTATTCTGGGTCCG-3’) and GAPDH (sense 5′-GAAGGTGAAGGTCGGAGTCA-
3′; antisense 5′-TTCACACCCATGACGAACAT-3′). After a hot start, the amplification profile 
was 30 cycles of 1 min denaturation at 94°C, 1 min annealing at 68°C, and 1 min extension at 
72°C for caspase-3; 25 cycles of 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C for Fas; 25 
cycles of 1 min at 94°C, 1 min at 55°C, and 1 min at 72°C for GAPDH. A no cDNA control 
containing no template was included in all experiments to ensure no genomic 
contamination. The PCR products were analysed by electrophoresis on 1-2.5% agarose gels 
containing ethidium bromide and images were captured using Syngene GeneSnap and 
GeneTools software on a ChemiDoc system. 
 
Statistical analysis 
Statistical analyses were carried using GraphPad Prism® software (GraphPad Software, Inc., 
California, USA). Results are expressed as mean ± SEM. Means were compared by unpaired 
t-test, Mann Whitney test, one-way analysis of variance (ANOVA) or Kruskal-Wallis test as 
appropriate. A P value of  0.05 was considered to represent a statistically significant 
difference (* P  0.05; ** P  0.01; *** P  0.001). Experiments were performed a minimum 
of three times.  
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Results 
Evaluation of baseline apoptosis and caspase-3 activity in CF and non-CF epithelial cells 
Using a commercial assay, relative levels of apoptosis (DNA fragmentation) were found to 
be significantly elevated in both CF tracheal (CFTE, Figure 1A) and bronchial (CFBE, Figure 
1B) epithelial cells compared to corresponding non-CF control cell lines (HTE and HBE). 
Caspase-3 activity was detected using the fluorogenic substrate Ac-DEVD-AMC and was 
significantly increased in both CFTE and CFBE cells compared to corresponding healthy 
control cell lines (HTE and HBE) (Figure 1C, D). No difference in caspase-3 mRNA expression 
was detected (Figure 1E) suggesting the increased caspase-3 activity observed in CF 
epithelial cells may be a post-translational alteration in caspase-3 activity or activation of 
pre-existing caspase-3, and may be related to dysfunctional CFTR. Furthermore, increased 
cleaved caspase-3 protein in CFTE and CFBE versus HTE and HBE cell lysates was confirmed 
by Western blot (Figure 1F). Proliferation rates were not found to vary in CFBEs versus HBEs 
and CFTEs versus HTEs indicating that alterations in proliferation do not contribute to 
changes in baseline apoptosis and caspase activity observed in CF versus non-CF cell lines 
(data not shown). 
 
Increased active caspase-8 contributes to increased caspase-3 activity in CF epithelial cells  
Caspase-8 activity was analysed in whole cell lysates using the caspase-8 substrate Ac-IETD-
AMC and was found to be significantly elevated in CF tracheal (Figure 2A) and bronchial 
(Figure 2B) epithelial cells compared to non-CF controls. In order to confirm the presence of 
increased functional, active caspase-8 in CF epithelial cells, we subsequently examined the 
status of tBID, a substrate for caspase-8, by Western blotting  [19]. As illustrated in Figure 
2C, increased amounts of tBID were detectable in both CFTE and CFBEs compared to their 
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respective non-CF control cells confirming the presence of active caspase-8 in CF epithelial 
cells. In addition, evidence of increased cleaved caspase-8 in CFTE and CFBE versus HTE and 
HBE cell lysate was demonstrated by Western blot (Figure 2D). Another well-known 
downstream target of active caspase-8 is caspase-3 and effects of caspase-8 inhibition on 
caspase-3 activity were also analysed [20]. Treatment of CFTE (Figure 2E) and CFBE (Figure 
2F) with the caspase-8 inhibitor Ac-IETD-CHO resulted in a significant decrease in the levels 
of caspase-3 activity which was observed in both cell types. Overall, these findings suggest 
that caspase-8 is active and functional in CF tracheal and bronchial epithelial cells compared 
to non-CF controls.  
 
Investigating the relationship between caspase activity and CFTR function 
To investigate the relationship between upregulated caspase-3 activity in CF epithelial cell 
lines and dysfunctional CFTR, we incubated non-CF control tracheal (Figure 3A) and 
bronchial (Figure 3B) epithelial cell lines and primary NHBEs with the thiazolidinone 
compound CFTRinh- 172 in order to induce a ‘CF-like’ phenotype in these cells (Figure 3C). 
Following a 24 hr incubation, significantly increased levels of caspase-3 activity were 
detected in non-CF epithelial cells treated with CFTRinh- 172. 
 
Up-regulated Fas expression and activation in CF epithelial cells  
Fas mediates signals for cell death through the extrinsic pathway and previous work 
suggests that the status of CFTR can alter Fas levels and activity [10,21] . Subsequently, Fas 
expression was explored in CF epithelial cells. As illustrated in Figure 4A, the Fas mRNA was 
upregulated in both CF tracheal and bronchial cells compared to non-CF control cells. In 
agreement, protein levels of Fas were also up-regulated in CF epithelial cells (Figure 4B). To 
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investigate the role of CFTR dysfunction in the control of Fas expression, non-CF NHBE cells 
were treated with CFTRinh-172 for 24 hr and Fas mRNA and protein levels analysed. Following 
CFTR inhibition, both Fas mRNA (Figure 4C) and protein (Figure 4D) levels increased 
compared to untreated cells. In addition, significantly increased Fas mRNA levels were also 
significantly detected in vivo in bronchial brush samples obtained from patients with CF 
compared to non-CF controls (Figure 4E). These findings suggest that CFTR dysfunction 
contributes to an increase in the levels of Fas mRNA and protein in CF epithelial cells. 
 
Increased susceptibility of CF epithelial cells to Fas-induced apoptosis 
The role of Fas in inducing elevated levels of caspase-3 activity detected in CF epithelial cells 
was investigated. CF epithelial cells were treated with an anti-Fas neutralising antibody 
(clone ZB4) or isotype control antibody and the effects on caspase-3 activity were evaluated 
by fluorogenic activity assay. As depicted in Figure 5, neutralisation of Fas resulted in a 
significant decrease in caspase-3 activity in both CFTE (Figure 5A) and CFBE (Figure 5B) 
compared to treatment with isotype control antibody. Following treatment of epithelial cells 
with a human Fas activating antibody (CH-11), whole cell lysates were analysed for levels of 
apoptosis and caspase-3 activity. Exposure of epithelial cells to CH-11 resulted in the 
upregulation of apoptosis (DNA fragmentation), however, this upregulation was significantly 
higher in both the CFTEs (Figure 5C; 390% vs 161%, P < 0.05) and CFBEs (Figure 5D; 218% vs 
145%, P < 0.05) compared to corresponding control cells. A similar trend was observed for 
CH-11-induced caspase-3 activity. Following CH-11 treatment, both CFTEs (Figure 5E; 228% 
vs 114%, P < 0.01) and CFBEs (Figure 5F; 192% vs 142%, P < 0.05) displayed significantly 
increased levels of caspase-3 activity compared to non-CF controls.  
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Discussion 
In this study we demonstrate that CF epithelial cells exhibit features of apoptosis in their 
basal, unstimulated state including increased caspase (-3 and -8) activation compared to 
non-CF epithelial cells. Analysis of factors responsible for this basal activation revealed 
upregulated Fas expression and protein levels in CF cells. Upon activation with the CH-11 
(Fas activating) antibody there was a more pronounced increase in apoptosis in CF cells 
compared to non-CF cells with significant upregulation of apoptosis and caspase activity. 
These data indicate that CF epithelium is in a ‘primed’ state of activation in the basal state 
and becomes more overtly apoptotic upon activation. However, it is clear that other factors 
are involved in upregulated caspase-3 activity in CF epithelial cells as inhibition of Fas 
signalling (Figure 5) did not completely inhibit caspase-3 activation in our CF cell lines. 
 
Evidence of ER stress has been demonstrated in CF epithelium [22]. However, we did not 
detect any sign of ER stress in our cells (data not shown) although it has to be stated that 
our studies focused primarily on unstimulated cells in contrast to the previous ER stress 
studies in CF. We have observed increased expression of Fas in CF cells compared to non-CF 
cells. We also evaluated Fas ligand (FasL) expression in our cell lines but did not observe 
evidence of increased FasL expression in the CF cells (data not shown). The Fas receptor is a 
death receptor present on the cell surface that can be activated resulting in programmed 
cell death. Fas forms the death-inducing signaling complex (DISC) upon ligand binding and 
contains a death effector domain (DED) near its amino terminus which facilitates binding to 
the DED of caspase-8  [23]. It has previously been demonstrated that Fas expression is 
increased in conjunctival epithelial cells from CF patients compared to non-CF patients [21]. 
Another study showed that Fas expression in CF and non-CF lung tissue was comparable 
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although this was determined semi-quantitatively by immunohistochemistry [13]. In 
addition, allelic variants within Fas intron 2 generate functional variants of Fas that can 
modulate the manifestation of CF disease [24]. Fas expression may be altered by CFTR 
channel activity in CF epithelial cells which may explain, in part, the mechanism of elevated 
basal apoptosis in these cells. However, this requires further analysis. In the setting of the 
lung, increased apoptosis resulting from inhalation of anti-Fas antibody in rodents results in 
significantly increased lung inflammation [25]. Likewise, instillation of the pro-apoptotic 
compound, ceramide, results in increased apoptosis in the lungs of mice leading to 
development of emphysema [26]. 
 
Our finding of altered apoptosis in CF epithelial cells has the potential to impact on 
epithelial integrity in the lung although it should be pointed out that others have observed 
altered effects on apoptosis in CF epithelium during Pseudomonas infection [4,27–29] and 
conditions of oxidative stress [7,30]. Therefore, it seems likely that alterations in apoptosis 
(decreased or increased) are dependent on the environment and/or stimuli present in the 
CF lung and may depend on the presence of specific factors of epithelial and bacterial origin. In 
the context of our findings, more work is required to explain why Fas expression is increased 
in CF cells and how activation of this receptor leads to increased apoptosis in CF epithelial 
cells. Further analysis of other cell signalling pathways involved in apoptosis in CF cells is 
also warranted including analysis of both extracellular factors that could influence the 
extrinsic pathway as well as factors regulating the intrinsic apoptosis pathway. In 
conclusion, our data demonstrates that alterations in apoptosis in epithelial cells is basally 
increased in CF epithelium and requires further investigation for assessment of impact on 
infection and inflammation in the CF airways. 
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Figure Legends 
Figure 1. Increased basal apoptosis and caspase-3 levels in CF epithelial cells.  
Baseline apoptosis (DNA fragmentation) was detected in non-CF (HTE, HBE) and CF (CFTE, 
CFBE) (A) tracheal and (B) bronchial epithelial cells using the TiterTACS™ Colorimetric 
Apoptosis Detection Kit. The results are expressed as a % of the respective non-CF control 
(n=6 for each group). Caspase-3 activity was detected in non-CF and CF (C) tracheal and (D) 
bronchial epithelial cell lines using the fluorogenic substrate Ac-DEVD-AMC. Results are 
expressed as the relative fluorescence units (RFU) per min normalised to protein 
concentration (n=6 for each group). (E) Caspase-3 and GAPDH mRNA expression were 
detected by RT-PCR (representative agarose gel from n=3). (F). Cleaved caspase-3 protein 
was detected by Western blot (representative Western blot from n=3). 
 
Figure 2. Increased caspase-8 activity in CF epithelial cells activates caspase-3.  
Caspase-8 activity was analysed in (A) tracheal and (B) bronchial epithelial cell whole cell 
lysates using the fluorogenic Ac-IETD-AMC substrate. Results are expressed as the relative 
fluorescence units (RFU) per min normalised to protein concentration (n=6 for each group). 
(C) Cleavage of Bid to its truncated form (tBid, 15 KDa) was detected by Western blotting of 
non-CF and CF tracheal (HTE, CFTE) and bronchial (HBE, CFBE) epithelial cell whole cell 
lysates. GAPDH was used as a loading control. (D) Caspase-8 protein was detected by 
Western blot (representative Western blot from n=3). Caspase-3 activity detected in (E) 
CFTEs and (F) CFBEs treated in the absence or presence of a caspase-8 inhibitor (Casp8-inh, 
Ac-IETD-CHO, 10 μM) for 24 hr. Cells were lysed and caspase-3 activity was detected using 
Ac-DEVD-AMC. Results are expressed as a % of untreated control cells (n=6 for each group).  
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Figure 3. Effects of CFTR inhibition on epithelial cell caspase-3 activity. 
(A) Non-CF tracheal (HTE), (B) bronchial (HBE) and (C) primary human tracheal/bronchial 
epithelial cells (NHBE) were treated in the absence or presence of a CFTR inhibitor (CFTRinh-
172 20 μM) for 24 hr. Caspase-3 activity was detected in whole cell lysates using the 
fluorogenic substrate Ac-DEVD-AMC. Results are expressed as a % of respective untreated 
control cells. 
 
Figure 4. CF epithelial cells express increased levels of Fas (CD95). 
(A) Fas mRNA expression was detected in tracheal and bronchial epithelial cell lines by RT-
PCR. GAPDH was used as a loading control (representative agarose gel from n=4). (B) 
Western blotting of Fas and GAPDH in tracheal and bronchial epithelial cell line whole cell 
lysates (representative Western blot from n=4). Non-CF primary human tracheal/bronchial 
epithelial cells (NHBE) were treated in the absence or presence of a CFTR inhibitor (CFTRinh-
172; 20 μM) for 24 hr and the effects on (C) Fas mRNA and (D) Fas protein detected by RT-
PCR and Western blotting, respectively. (E) Fas mRNA expression in CF and non-CF control 
bronchial brushings (n=3) were quantified by qRT-PCR as described in the methods. 
 
Figure 5. Inhibition of Fas down-regulates caspase-3 activity in CF epithelial cells. 
(A) CFTEs and (B) CFBEs were treated with isotype control or anti-Fas neutralising antibody 
(clone ZB4, 100 ng/ml) for 6 hr. Cells were lysed and caspase-3 activity measured using the 
fluorogenic substrate Ac-DEVD-AMC. Results are expressed as a % of untreated controls. * P 
< 0.05. CF and non-CF tracheal and bronchial epithelial cell lines were stimulated with the 
Fas activating antibody CH-11 (0.5 g/ml) for 24 hr (n=6 for each group). (C, D) Apoptosis 
(DNA fragmentation) was quantified using the using the TiterTACS™ Colorimetric Apoptosis 
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Detection Kit. Results are expressed as a % of respective untreated control and groups were 
compared by one way ANOVA (n=8 for each group). (E, F) Caspase-3 activity was detected 
using the Ac-DEVD-AMC fluorogenic substrate. Results are expressed as a % of respective 
untreated control and groups were compared by one way ANOVA (n=8 for each group).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
References 
[1] Starner TD, McCray PB, American College of Physicians, American Physiological 
Society. Pathogenesis of early lung disease in cystic fibrosis: a window of opportunity 
to eradicate bacteria. Ann Intern Med 2005;143:816–22. 
[2] Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. 
Identification of the cystic fibrosis gene: cloning and characterization of 
complementary DNA. Science 1989;245:1066–73. 
[3] Rogan MP, Stoltz DA, Hornick DB. Cystic fibrosis transmembrane conductance 
regulator intracellular processing, trafficking, and opportunities for mutation-specific 
treatment. Chest 2011;139:1480–90. doi:10.1378/chest.10-2077. 
[4] Cannon CL, Kowalski MP, Stopak KS, Pier GB. Pseudomonas aeruginosa-induced 
apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis 
transmembrane conductance regulator. Am J Respir Cell Mol Biol 2003;29:188–97. 
doi:10.1165/rcmb.4898. 
[5] Gottlieb RA, Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator 
inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. 
Proc Natl Acad Sci U S A 1996;93:3587–91. 
[6] Chaudhary N, Datta K, Askin FB, Staab JF, Marr KA. Cystic fibrosis transmembrane 
conductance regulator regulates epithelial cell response to Aspergillus and resultant 
pulmonary inflammation. Am J Respir Crit Care Med 2012;185:301–10. 
doi:10.1164/rccm.201106-1027OC. 
[7] Voisin G, Bouvet GF, Legendre P, Dagenais A, Massé C, Berthiaume Y. Oxidative stress 
modulates the expression of genes involved in cell survival in ΔF508 cystic fibrosis 
airway epithelial cells. Physiol Genomics 2014;46:634–46. 
18 
 
doi:10.1152/physiolgenomics.00003.2014. 
[8] Rottner M, Kunzelmann C, Mergey M, Freyssinet J-M, Martínez MC. Exaggerated 
apoptosis and NF-kappaB activation in pancreatic and tracheal cystic fibrosis cells. 
FASEB J 2007;21:2939–48. doi:10.1096/fj.06-7614com. 
[9] Maiuri L, Raia V, De Marco G, Coletta S, de Ritis G, Londei M, et al. DNA 
fragmentation is a feature of cystic fibrosis epithelial cells: a disease with 
inappropriate apoptosis? FEBS Lett 1997;408:225–31. 
[10] Bodas M, Min T, Vij N. Critical role of CFTR-dependent lipid rafts in cigarette smoke-
induced lung epithelial injury. Am J Physiol Lung Cell Mol Physiol 2011;300:L811-20. 
doi:10.1152/ajplung.00408.2010. 
[11] Yalçin E, Talim B, Ozçelik U, Doğru D, Cobanoğlu N, Pekcan S, et al. Does defective 
apoptosis play a role in cystic fibrosis lung disease? Arch Med Res 2009;40:561–4. 
doi:10.1016/j.arcmed.2009.07.005. 
[12] Abu-El-Haija M, Ramachandran S, Meyerholz DK, Abu-El-Haija M, Griffin M, Giriyappa 
RL, et al. Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the 
activation of inflammatory and remodeling pathways. Am J Pathol 2012;181:499–507. 
doi:10.1016/j.ajpath.2012.04.024. 
[13] Durieu I, Amsellem C, Paulin C, Chambe MT, Bienvenu J, Bellon G, et al. Fas and Fas 
ligand expression in cystic fibrosis airway epithelium. Thorax 1999;54:1093–8. 
[14] Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, et al. 
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell 
clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002;109:661–70. 
doi:10.1172/JCI13572. 
[15] Vandivier RW, Richens TR, Horstmann SA, deCathelineau AM, Ghosh M, Reynolds SD, 
19 
 
et al. Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits 
phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol 
Lung Cell Mol Physiol 2009;297:L677-86. doi:10.1152/ajplung.00030.2009. 
[16] Ornatowski W, Poschet JF, Perkett E, Taylor-Cousar JL, Deretic V. Elevated furin levels 
in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced 
cytotoxicity. J Clin Invest 2007;117:3489–97. doi:10.1172/JCI31499. 
[17] Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O’Neill SJ, McElvaney NG, et al. miR-
126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 
expression. J Immunol 2010;184:1702–9. doi:10.4049/jimmunol.0902669. 
[18] Weldon S, McNally P, McAuley DF, Oglesby IK, Wohlford-Lenane CL, Bartlett JA, et al. 
miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary 
cathepsin S production. Am J Respir Crit Care Med 2014;190:165–74. 
doi:10.1164/rccm.201311-1986OC. 
[19] Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial 
damage in the Fas pathway of apoptosis. Cell 1998;94:491–501. 
[20] Stennicke HR, Jürgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, et al. Pro-
caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084–90. 
[21] Mrugacz M. Fas Expression in Conjunctival Epithelial Cells of Patients With Cystic 
Fibrosis. J Interf Cytokine Res 2009;29:735–40. doi:10.1089/jir.2008.0111. 
[22] Martino MEB, Olsen JC, Fulcher NB, Wolfgang MC, O’Neal WK, Ribeiro CMP. Airway 
epithelial inflammation-induced endoplasmic reticulum Ca2+ store expansion is 
mediated by X-box binding protein-1. J Biol Chem 2009;284:14904–13. 
doi:10.1074/jbc.M809180200. 
[23] Dickens LS, Boyd RS, Jukes-Jones R, Hughes MA, Robinson GL, Fairall L, et al. A death 
20 
 
effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly 
in mediating apoptotic cell death. Mol Cell 2012;47:291–305. 
doi:10.1016/j.molcel.2012.05.004. 
[24] Kumar V, Becker T, Jansen S, van Barneveld A, Boztug K, Wölfl S, et al. Expression 
levels of FAS are regulated through an evolutionary conserved element in intron 2, 
which modulates cystic fibrosis disease severity. Genes Immun 2008;9:689–96. 
doi:10.1038/gene.2008.63. 
[25] Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, et al. Induction 
of Apoptosis and Pulmonary Fibrosis in Mice in Response to Ligation of Fas Antigen. 
Am J Respir Cell Mol Biol 1997;17:272–8. doi:10.1165/ajrcmb.17.3.2893. 
[26] Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, et al. Ceramide 
upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. 
Nat Med 2005;11:491–8. doi:10.1038/nm1238. 
[27] Cobb LM, Mychaleckyj JC, Wozniak DJ, López-Boado YS. Pseudomonas aeruginosa 
flagellin and alginate elicit very distinct gene expression patterns in airway epithelial 
cells: implications for cystic fibrosis disease. J Immunol 2004;173:5659–70. 
[28] Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heerckeren A, et al. 
Pseudomonas aeruginosa Induction of Apoptosis in Respiratory Epithelial Cells. Am J 
Respir Cell Mol Biol 2000;23:304–12. doi:10.1165/ajrcmb.23.3.4098. 
[29] Jendrossek V, Grassmé H, Mueller I, Lang F, Gulbins E. Pseudomonas aeruginosa-
induced apoptosis involves mitochondria and stress-activated protein kinases. Infect 
Immun 2001;69:2675–83. doi:10.1128/IAI.69.4.2675-2683.2001. 
[30] Abdalla MY, Hoke T, Seravalli J, Switzer BL, Bavitz M, Fliege JD, et al. Pseudomonas 
Quinolone Signal Induces Oxidative Stress and Inhibits Heme Oxygenase-1 Expression 
21 
 
in Lung Epithelial Cells. Infect Immun 2017;85:e00176-17. doi:10.1128/IAI.00176-17. 
 
 
 
 
 
Figure 1
A                                                            B 
E F                                                              
Caspase-3
GAPDH
HTE   CFTE    HBE   CFBE                  
HBE CFBE
0
100
200
300
400
500
***
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(R
F
U
/m
in
/ 
g
 p
ro
te
in
)
HTE CFTE
0
100
200
300
400
500
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(R
F
U
/m
in
/ 
g
 p
ro
te
in
)
HTE CFTE
0
100
200
300
*
A
p
o
p
to
s
is
(%
 n
o
n
-C
F
 c
o
n
tr
o
l)
HBE CFBE
0
100
200
300
400
*
A
p
o
p
to
s
is
(%
 n
o
n
-C
F
 c
o
n
tr
o
l)
C                                                            D 
HTE    CFTE   HBE   CFBE                  
Active 
caspase-3
GAPDH
Figure 2
C
E
A B
HTE CFTE
0
50
100
150
200
**
C
a
s
p
a
s
e
-8
 a
c
ti
v
it
y
(R
F
U
/m
in
/ 
g
 p
ro
te
in
)
HBE CFBE
0
50
100
150
200
250 ***
C
a
s
p
a
s
e
-8
 a
c
ti
v
it
y
(R
F
U
/m
in
/ 
g
 p
ro
te
in
)
F
HTE           CFTE                   HBE              CFBE               
tBid (p15)
GAPDH
CFTE CFTE + Casp8-inh
0
50
100
150
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
c
o
n
tr
o
l)
CFBE CFBE + Casp8-inh
0
50
100
150
***
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
c
o
n
tr
o
l)
HTE    CFTE      HBE   CFBE
Pro-caspase-8 
(p55/53)
Active caspase-8
(p18)
GAPDH
D
Figure 3
A
HBE HBE + CFTRinh-172
0
50
100
150 *
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
HTE HTE + CFTR inh-172
0
50
100
150
200
250
**
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
B
NHBE NHBE + CFTRinh-172
0
50
100
150
200
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
C D
CFBE corr CFBE
0
200
400
600
800
**
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(R
F
U
/m
in
/ 
g
 p
ro
te
in
)
Fas
GAPDH
HTE             CFTE                  HBE              CFBE
B
Figure 4
A                                                                                       
Fas
GAPDH
HTE              CFTE                HBE             CFBE               
Non-CF CF
0.0
0.2
0.4
0.6
0.8
1.0
F
a
s
 (
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
)
*
E
C                                               D
Fas
GAPDH
0         10         20       
CFTR-inh172 (μM)
Fas
GAPDH
0        10        20       
CFTR-inh172 (μM)
Figure 5
A B
CFTE CFTE + anti-Fas
0
50
100
150
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
c
o
n
tr
o
l)
CFBE CFBE + anti-Fas
0
50
100
150
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
c
o
n
tr
o
l)
C                                                               D
E F
HTE HTE + CH-11 CFTE CFTE + CH-11
0
100
200
300
400
500
600
**
**
*
A
p
o
p
to
s
is
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
HBE HBE + CH-11 CFBE CFBE + CH-11
0
50
100
150
200
250 **
*
A
p
o
p
to
s
is
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
HBE HBE + CH-11 CFBE CFBE + CH-11
0
50
100
150
200
250
**
***
*
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
HTE HTE + CH-11 CFTE CFTE + CH-11
0
50
100
150
200
250 **
**
C
a
s
p
a
s
e
-3
 a
c
ti
v
it
y
(%
 o
f 
u
n
tr
e
a
te
d
 c
o
n
tr
o
l)
